Risk Stratification for Trial Enrichment Considering Loco‐Regional Failure in Head and Neck Cancer: UICC8 Versus Purpose‐Built Failure‐Type Specific Risk Prediction Model

Authors:

Abstract
Background: A previously published failure‐type specific risk model showed good performance in the original cohort. Aim: to validate the model and separate patients with high‐ and low‐risk loco‐regional failure (LRF). Goal: to identify patients potentially suitable for treatment intensification trials.Methods: Validation data: 756 patients from two institutions (different countries). Predictive performance was evaluated by Brier scores and AUCs. Discriminatory performance was compared to Union for International Cancer Control (UICC) staging (versions 7 and 8).Results: The model's 3‐year AUC for LRF was 65%, significantly better than UICC7 staging, but no significant difference to UICC8. Model‐based risk stratification and UICC8 both identified high‐risk patient groups with 3‐year LRF ≈30%. The population mean was 18%.Conclusions: The model performed well on a group level. UICC8 staging performed equally well. Although developed for the endpoint of OS, an improvement from UICC version 7 to version 8 was evident also for the prediction of LRF.
Funding Information
  • Varian Medical Systems

This publication has 18 references indexed in Scilit: